NASDAQ: TNONTenon Medical Inc Stock
$0.23+0.00 (+0%)
Updated Jul 10, 2026
TNON Price
$0.23
Fair Value Price
N/A
Market Cap
$2.62M
52 Week Low
$0.22
52 Week High
$2.48
P/E
-0.18x
P/B
1.38x
P/S
1.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.60M
Earnings
-$12.42M
Gross Margin
64.8%
Operating Margin
-266.26%
Profit Margin
-270.1%
Debt to Equity
5.78
Operating Cash Flow
-$11M
Beta
0.97
Next Earnings
Aug 12, 2026
Ex-Dividend
N/A
Next Dividend
N/A
TNON Overview
Tenon Medical Incorporated is a medical device company that develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgeries and outcomes. Its CATAMARAN SIJ Fusion System includes instruments and implants. The company was incorporated in 2012 and is based in Los Gatos, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TNON's potential to beat the market
- TNON doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
TNON
RankedUnranked of 95
RankedUnranked of 95
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.88 | A | |
| $45.65 | A | |
| $29.83 | A |
Be the first to know about important TNON news, forecast changes, insider trades & much more!
TNON News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TNON scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TNON is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TNON is good value based on its book value relative to its share price (1.38x), compared to the US Medical Devices industry average (3.1x)
P/B vs Industry Valuation
TNON is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TNON due diligence checks available for Premium users.
Valuation
TNON price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.18x
Industry
21.15x
Market
12.99x
TNON price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.38x
Industry
3.1x
TNON is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TNON's financial health
Profit margin
Revenue
$1.4M
Net Income
-$3.5M
Profit Margin
-252.1%
TNON's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TNON's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.8M
Liabilities
$10.9M
Debt to equity
5.78
TNON's short-term assets ($7.62M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TNON's short-term assets ($7.62M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TNON's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.0M
Investing
-$56.0k
Financing
$3.9M
TNON's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TNON vs Medical Device Stocks
Tenon Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.